Evidence map›Paper›PMID 29396534›Full record

ArticleScientific reports2018

Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff.

Anneli Sundkvist, Robin Myte, Stina Bodén, Stefan Enroth, Ulf Gyllensten, Sophia Harlid, Bethany van Guelpen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anneli SundkvistDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Robin MyteDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.ORCID http://orcid.org/0000-0002-2974-2003
Stina BodénDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Stefan EnrothDepartment of Immunology, Genetics, and Pathology, Biomedical Center, Science for Life Laboratory Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-5056-9137
Ulf GyllenstenDepartment of Immunology, Genetics, and Pathology, Biomedical Center, Science for Life Laboratory Uppsala University, Uppsala, Sweden.
Sophia HarlidDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.ORCID http://orcid.org/0000-0001-8540-6891
Bethany van GuelpenDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. bethany.vanguelpen@umu.se.ORCID http://orcid.org/0000-0002-9692-101X
Umeå University · SEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lifestyle behaviors are believed to influence the body's inflammatory state. Chronic low-grade inflammation contributes to the development of major non-communicable diseases such as diabetes, cardiovascular disease and cancer. Inflammation may thus be an important link between lifestyle and disease. We evaluated self-reported physical activity, tobacco use and alcohol consumption in relation to plasma levels of 160 validated inflammatory and cancer biomarkers. The study included 138 participants from a population-based cohort, all with repeated sampling of plasma and data ten years apart, allowing consideration of both intra- and inter-individual variation. Of 17 relationships identified, the strongest was an independent, positive association between cornulin (CRNN) and Swedish moist snuff (snus) use. We replicated the finding in a second cohort of 501 individuals, in which a dose-response relationship was also observed. Snus explained approximately one fifth of the variance in CRNN levels in both sample sets (18% and 23%). In conclusion, we identified a novel, independent, dose-dependent association between CRNN and snus use. Further study is warranted, to evaluate the performance of CRNN as a potential snus biomarker. The putative importance of lifestyle behaviors on a wide range of protein biomarkers illustrates the need for more personalized biomarker cut-offs.

Indexed as

ProteomicsTobacco UseAdultAgedAged, 80 and overAlcohol DrinkingBiomarkersExerciseFemaleHumansMaleMembrane ProteinsMiddle AgedNeoplasm ProteinsPlasmaTobacco, SmokelessBiomarkersCRNN protein, humanMembrane ProteinsNeoplasm Proteins

Identifiers

PMID29396534
PMCPMC5797131
OpenAlexW2786520066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.